Sio Capital Management’s Aratana Therapeutics, Inc. PETX Stock Holding History

Sio Capital Management’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-59,869	Closed	-$378K	–	50
2016 Q2	$378K	Buy	+59,869	New	+$385K	0.19%	42
2016 Q1	–	Sell	-97,376	Closed	-$543K	–	55
2015 Q4	$543K	Sell	97,376 -42,780	-31%	-$283K	0.24%	38
2015 Q3	$1.19M	Sell	140,156 -264,582	-65%	-$4.48M	0.81%	27
2015 Q2	$6.12M	Buy	404,738 +226,188	+127%	+$3.27M	3.02%	8
2015 Q1	$2.86M	Sell	178,550 -146,870	-45%	-$2.61M	1.63%	16
2014 Q4	$5.8M	Buy	+325,420	New	+$4.05M	4.56%	6

Other funds holding PETX

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Sio Capital Management's PETX Position: Q3 2016 in Review

Sio Capital Management sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2016, closing a stake of 59,869 shares — an estimated $378K sold.

Sio Capital Management first reported a position in PETX in Q4 2014 and held it in 6 quarters. The position peaked at $6.12M in Q2 2015. 129 funds tracked by Wall St. Rank hold PETX as of Q3 2016.

Sio Capital Management reported no remaining Aratana Therapeutics, Inc. position as of Q3 2016 after selling out during the quarter.
Sio Capital Management sold 59,869 Aratana Therapeutics, Inc. shares in Q3 2016, an estimated $378K.
Sio Capital Management first reported a position in Aratana Therapeutics, Inc. in Q4 2014 and held it in 6 quarters.
Sio Capital Management's Aratana Therapeutics, Inc. position peaked at $6.12M in Q2 2015.
129 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2016.

Based on Sio Capital Management's 13F filing for Q3 2016, filed 15 Nov 2016.